MGMT and glioblastoma: The European guidelines state that patients with GBM with MGMT-methylation aged ≥75 years may receive hypofractionated RT/TMZ or TMZ alone, and those with GBM without MGMT-methylation may receive hypofractionated RT alone, indicating that either RT or TMZ alone might be a treatment option [22].